Cargando…

Application of Radiosensitizers in Cancer Radiotherapy

Radiotherapy (RT) is a cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors. Although great success has been achieved on radiotherapy, there is still an intractable challenge to enhance radiation damage to tumor tissue and reduce side effects to healthy tissue. R...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Liuyun, Zhang, Yujie, Liu, Chengcheng, Zhang, Mingzhen, Han, Suxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886779/
https://www.ncbi.nlm.nih.gov/pubmed/33603370
http://dx.doi.org/10.2147/IJN.S290438
_version_ 1783651869340467200
author Gong, Liuyun
Zhang, Yujie
Liu, Chengcheng
Zhang, Mingzhen
Han, Suxia
author_facet Gong, Liuyun
Zhang, Yujie
Liu, Chengcheng
Zhang, Mingzhen
Han, Suxia
author_sort Gong, Liuyun
collection PubMed
description Radiotherapy (RT) is a cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors. Although great success has been achieved on radiotherapy, there is still an intractable challenge to enhance radiation damage to tumor tissue and reduce side effects to healthy tissue. Radiosensitizers are chemicals or pharmaceutical agents that can enhance the killing effect on tumor cells by accelerating DNA damage and producing free radicals indirectly. In most cases, radiosensitizers have less effect on normal tissues. In recent years, several strategies have been exploited to develop radiosensitizers that are highly effective and have low toxicity. In this review, we first summarized the applications of radiosensitizers including small molecules, macromolecules, and nanomaterials, especially those that have been used in clinical trials. Second, the development states of radiosensitizers and the possible mechanisms to improve radiosensitizers sensibility are reviewed. Third, the challenges and prospects for clinical translation of radiosensitizers in oncotherapy are presented.
format Online
Article
Text
id pubmed-7886779
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78867792021-02-17 Application of Radiosensitizers in Cancer Radiotherapy Gong, Liuyun Zhang, Yujie Liu, Chengcheng Zhang, Mingzhen Han, Suxia Int J Nanomedicine Review Radiotherapy (RT) is a cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors. Although great success has been achieved on radiotherapy, there is still an intractable challenge to enhance radiation damage to tumor tissue and reduce side effects to healthy tissue. Radiosensitizers are chemicals or pharmaceutical agents that can enhance the killing effect on tumor cells by accelerating DNA damage and producing free radicals indirectly. In most cases, radiosensitizers have less effect on normal tissues. In recent years, several strategies have been exploited to develop radiosensitizers that are highly effective and have low toxicity. In this review, we first summarized the applications of radiosensitizers including small molecules, macromolecules, and nanomaterials, especially those that have been used in clinical trials. Second, the development states of radiosensitizers and the possible mechanisms to improve radiosensitizers sensibility are reviewed. Third, the challenges and prospects for clinical translation of radiosensitizers in oncotherapy are presented. Dove 2021-02-12 /pmc/articles/PMC7886779/ /pubmed/33603370 http://dx.doi.org/10.2147/IJN.S290438 Text en © 2021 Gong et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Gong, Liuyun
Zhang, Yujie
Liu, Chengcheng
Zhang, Mingzhen
Han, Suxia
Application of Radiosensitizers in Cancer Radiotherapy
title Application of Radiosensitizers in Cancer Radiotherapy
title_full Application of Radiosensitizers in Cancer Radiotherapy
title_fullStr Application of Radiosensitizers in Cancer Radiotherapy
title_full_unstemmed Application of Radiosensitizers in Cancer Radiotherapy
title_short Application of Radiosensitizers in Cancer Radiotherapy
title_sort application of radiosensitizers in cancer radiotherapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886779/
https://www.ncbi.nlm.nih.gov/pubmed/33603370
http://dx.doi.org/10.2147/IJN.S290438
work_keys_str_mv AT gongliuyun applicationofradiosensitizersincancerradiotherapy
AT zhangyujie applicationofradiosensitizersincancerradiotherapy
AT liuchengcheng applicationofradiosensitizersincancerradiotherapy
AT zhangmingzhen applicationofradiosensitizersincancerradiotherapy
AT hansuxia applicationofradiosensitizersincancerradiotherapy